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Edited by Pascale CossartAbstract Mono-glucosylation of Rho, Rac, and Cdc42 by Clos-
tridium diﬃcile toxin B (TcdB) induces changes of actin dynam-
ics and apoptosis. When ﬁbroblasts were treated with TcdB, an
apparent decrease of the cellular Rac1 level was observed when
applying anti-Rac1(Mab 102). This decrease was not based on
degradation as inhibition of the proteasome by lactacystin did
not stabilise cellular Rac1 levels. The application of anti-Rac1
(Mab 23A8) showed that the cellular Rac1 level slightly in-
creased in TcdB-treated ﬁbroblasts; thus, the apparent loss of
cellular Rac1 was not due to degradation but due to impaired
recognition of glucosylated Rac1 by anti-Rac1 (Mab 102). In
contrast, recognition of RhoA by anti-RhoA (Mab 26C4) and
Cdc42 by anti-Cdc42 (Mab 44) was not altered by glucosylation;
a transient decrease of cellular RhoA and Cdc42 in TcdB-treated
ﬁbroblasts was indeed due to proteasomal degradation, as inhibi-
tion of the proteasome by lactacystin stabilised both cellular
RhoA and Cdc42 levels. The ﬁnding that the apparent decrease
of Rac1 reﬂects Rac1 glucosylation oﬀers a valuable tool to
determine Rac1 glucosylation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Low molecular weight GTPases of the Rho subfamily are
key regulators of essential cellular functions such as cytoskele-
tal dynamics, morphology, cytokinesis, cell–cell adhesion, cell
aggregation and apoptosis [1]. Several bacterial protein toxins
inactivate low molecular weight GTPases by covalent modiﬁ-
cation: (i) exoenzyme C3 from Clostridium botulinum is a
mono-ADP-ribosyltransferase that speciﬁcally modiﬁes
RhoA,B,C [2]; (ii) clostridial glucosylating toxins mono-
glucosylate low molecular weight GTPases: Clostridium diﬃ-
cile toxin A (TcdA) and toxin B (TcdB) and Clostridium novyi
a-toxin glucosylate Rho, Rac, and Cdc42; Clostridium sordellii
lethal toxin (TcsL) modiﬁes Rac, Ras, Ral, and Rap [3]. TheAbbreviations: GST, glutathione-S-transferase; Mab, monoclonal anti-
body; Pab, polyclonal antibody; TcdA, Clostridium diﬃcile toxin A;
TcdB, Clostridium diﬃcile toxin B; TcdBF, Clostridium diﬃcile toxin B
serotype F; TcsL, Clostridium sordellii lethal toxin
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and the glucose (Thr-37 in RhoA, Thr-35 in Rac1) are located
within the GTPases’ eﬀector region 1; both covalent modiﬁca-
tions irreversibly inhibit the conformational change of the
eﬀector region 1 after GTP binding. Unable to reach their ac-
tive conformation, the GTPases are rendered inactive [4,5].
Even though clostridial glucosylating toxins and exoenzyme
C3 represent generally accepted tools in cell biology to specif-
ically inactivate Rho-GTPases, only few data are available on
the inﬂuence of glucosylation on the cellular levels of their sub-
strate GTPases. In line with published reports, this study
shows that cellular levels of Rac1 apparently decreased [6–8].
We present evidence that the decreased level of cellular Rac1
is not due to degradation, but rather a result of impaired rec-
ognition with the commonly applied anti-Rac1 (Mab 102).
This ﬁnding is introduced as a valuable tool to speciﬁcally esti-
mate the glucosylation of Rac1 and prompted us to re-investi-
gate on the level of the TcdB substrates RhoA, RhoB, and
Cdc42.2. Materials and methods
2.1. Materials
TcdB (strain VPI10463) was puriﬁed from clostridia as described [9].
Recombinant GTPases were expressed using the pGEX-2T vector sys-
tem in Escherichia coli and puriﬁed with GSH-Sepharose Beads (AP
Biotech). Reagents obtained from commercial sources were: UDP-
[14C]glucose (Bio Trend), lactacystin (Calbiochem), ECL reagent
(Pierce), nitrocellulose membrane (Schleicher & Schuell). Antibodies:
b-actin (Mab AC-40) (Sigma–Aldrich); RhoA (Mab 26C4), GST
(Pab Z-5) (SantaCruz Biotechnologies); Cdc42 (Mab 44), Rac1 (Mab
102) (BD Transduction Laboratories); Rac1 (Mab 23A8) (Upstate);
RhoB (Pab BL927) (Bethyl Laboratories); horseradish peroxidase con-
jugated secondary antibodies mouse/rabbit (Rockland).
2.2. Cell culture
NIH3T3 ﬁbroblasts were cultivated in Dulbecco’s medium (Bio-
chrom, +10% FCS, 100 lg/ml penicillin, 100 lg/ml streptomycin and
1 mM sodium pyruvate) at 37 C and 5% CO2. Upon conﬂuence, cells
were passaged. For all experiments, sub conﬂuent cells in 3 cm dishes
were used.
2.3. Glucosylation reaction
Recombinant glutathione-S-transferase (GST)-GTPases were incu-
bated with and without toxin B (100 ng/ml) in glucosylation buﬀer
(50 mM HEPES, pH 7.5, 100 mM KCl, 1 mM MnCl2, 2 mM MgCl2,
100 lg/ml bovine serum albumin, 40 lM UDP-[14C]glucose) at 37 C
for 20 min. The reaction was terminated by addition of Laemmli
sample buﬀer. Proteins were separated by SDS–PAGE and analysed
by immuno-blotting and PhosphorImaging (Cyclone, Packard).blished by Elsevier B.V. All rights reserved.
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Sample proteins were separated using SDS–PAGE and subsequently
transferred onto nitrocellulose membranes by a wet blot system. The
membranes were blocked with 5% (w/v) non-fat dried milk, incubation
with the primary antibody was conducted over night at 4 C. After
treatment of the membrane with the secondary antibody (1 h), proteins
were detected with Enhanced Chemiluminescence Reagent (Pierce).3. Results
3.1. Cellular levels of Rac1 and RhoA in C. difficile toxin
B-treated ﬁbroblasts
Previous reports have shown that treatment of several mam-
malian cell lines with TcdB resulted in decreased levels of cel-
lular Rac1 protein [6–8]. This result is conﬁrmed here for
TcdB-treated NIH 3T3 ﬁbroblasts. Cellular levels of Rac1,
RhoA, and Cdc42 were determined using the commonly ap-
plied anti-Rac1 (Mab 102), anti-RhoA (Mab 26C4), and
anti-Cdc42 (Mab 44) antibodies. Degradation of Rho-GTP-
ases from TcdB-treated cells was more profound when higher
concentrations of TcdB were applied (Fig. 1). The loss of Rac1
was almost complete after 3 h, whereas the level of RhoA and
Cdc42 only decreased to about a third of the level in untreated
cells (Fig. 1). To check whether the loss of Rho-GTPases in
TcdB-treated cells was due to degradation, ﬁbroblasts were
incubated with the proteasome inhibitor lactacystin prior to
toxin-treatment. Lactacystin pre-treatment increased the basal
level of RhoA but not of Rac1 and Cdc42 (Fig. 1). Unexpect-
edly, the level of Rac1 from TcdB-treated ﬁbroblasts was
hardly stabilised by lactacystin (Fig. 1) or MG132 (data not
shown). In contrast, cellular levels of RhoA and Cdc42 clearly
increased due to protection from degradation by lactacystin
(Fig. 1). This demonstrated the eﬃcacy of lactacystin, as well.
As inhibition of the proteasome did not, Rac1 was not de-
graded in a proteasome-dependent manner.
Treatment of ﬁbroblasts with TcdA results in upregulation
of RhoB [10], a feature that was also found to be true for
TcdB. Cellular RhoB level were analysed applying anti-RhoB
(Pab BL927). RhoB was upregulated in response to TcdB
(Fig. 1). RhoB, however, was also upregulated by lactacystin
alone for 4 h by factor 1.7 compared to untreated ﬁbroblastsFig. 1. Inﬂuence of lactacystin on the cellular stability of Rho-
GTPases in TcdB-treated ﬁbroblasts (concentration dependent).
NIH3T3 ﬁbroblasts were incubated with lactacystin (30 lM) for 1 h
or left untreated. The indicated concentrations of TcdB were then
applied for another 3 h. Subsequently, cells were lysed directly in
Laemmli sample buﬀer. Rho-GTPase and b-actin levels were analysed
by Western blotting with the antibodies indicated.(data not shown). In this line, combined treatment of ﬁbro-
blasts with lactacystin and TcdB resulted in higher RhoB level,
compared to the level in ﬁbroblasts treated with TcdB alone
(Fig. 1). Thus, the level of cellular RhoA decreased, whereas
the level of RhoB protein increased in response to TcdB. As
RhoA and RhoB exhibited distinct proﬁles of the cellular level
in TcdB-treated ﬁbroblasts, the applied anti-RhoA (Mab
26C4) turned out be speciﬁc for RhoA and that anti-RhoB
(Pab BL927) turned out to be speciﬁc for RhoB.
The intracellular levels of Rac1, RhoA, RhoB, and Cdc42 in
TcdB-treated ﬁbroblasts were further recorded in a time-
dependent manner (Fig. 2A). The level of Rho-GTPases was
analysed densitometrically and normalised to the b-actin level
(Fig. 2B). The b-actin level was not altered by TcdB (Fig. 2A).
The Rac1 level decreased in TcdB-treated ﬁbroblasts (Fig. 2),
an observation also found in ﬁbroblasts that were treated with
other Rac1-glucosylating toxins, such as TcsL and TcdBF
(data not shown). The loss of Rac1 was much faster than the
loss of RhoA and Cdc42 and did not recover within 24 h,
whereas the loss of RhoA and Cdc42 was transient. The level
of RhoA and Cdc42 decreased with a minimum at about 7 h
(Fig. 2B). These observations were in fact striking, since the
more stable Rac1 (half life period of about 30 h) was faster de-
graded than RhoA (half life period of about 10 h) [11]. We ap-
plied an alternative anti-Rac1 (Mab 23A8) to further analyse
cellular Rac1 levels (Fig. 2); surprisingly, cellular Rac1 levels
increased about 3-fold in TcdB-treated ﬁbroblasts compared
to the level in untreated ﬁbroblasts; the elevated Rac1 level
persisted for 24 h. RhoB protein was upregulated by TcdB; ele-
vated RhoB levels also persisted for 24 h (Fig. 2). These obser-
vations suggested that the apparently decreasing levels of Rac1
in TcdB-treated ﬁbroblasts observed with anti-Rac1 (Mab 102)
were due to impaired recognition by anti-Rac1 (Mab 102) and
not due to degradation.3.2. Detection of glucosylated Rac1 in a cell-free experiment
To check whether the impaired recognition of Rac1 is a con-
sequence of its glucosylation, increasing amounts of [14C]glu-
cosylated or unmodiﬁed GST-Rac1 were analysed by Western
blotting applying anti-Rac1 (Mab 102) and the alternative
anti-Rac1 (Mab 23A8). PhosphorImager analysis visualised
the presence of [14C]glucosylated Rac1 (Fig. 3A). Glucosylated
and unmodiﬁed Rac1 were equally recognised by anti-Rac1
(Mab 23A8) (Fig. 3A). In contrast, the recognition of Rac1
using anti-Rac1 (Mab 102) depended on the state of modiﬁca-
tion. The level of Rac1 after glucosylation was lower than that
of unmodiﬁed Rac1 (Fig. 3A). Thus, glucosylation was most
likely to reduce the aﬃnity of anti-Rac1 (Mab 102) to Rac1,
as higher concentrations of glucosylated Rac1 as applied in
Fig. 3Awere partially recognised. Low amounts of glucosylated
Rac1 escaped recognition, so that cellular levels of glucosylated
Rac1 were not recognised by anti-Rac1 (Mab 102) (Figs. 1 and
2). To ﬁnd out whether the reduced recognition of glucosylated
Rac1 depended on its denaturation by SDS, glucosylated and
unmodiﬁed recombinant Rac1 were spotted directly onto a
nitrocellulose membrane. The recognition of glucosylated
Rac1 was reduced in comparison to unmodiﬁed Rac1 when
applying anti-Rac1 (Mab 102), whereas glucosylated and
unmodiﬁed Rac1 was equally detected by anti-Rac1 (Mab
23A8) (data not shown). In conclusion, the reduced recognition
of glucosylated Rac1 by anti-Rac1 (Mab 102) is most likely
Fig. 2. Cellular stability of glucosylated Rho-GTPases (time dependent). (A) NIH3T3 ﬁbroblasts were treated with 1 ng/ml of TcdB. Cells were
washed and lysed directly in Laemmli sample buﬀer after the incubation times indicated. Rho-GTPase and b-actin levels were analysed by
immunoblot with the antibodies indicated. (B) For graphical depiction, Western signal intensity was analysed densitometrically. Rho-GTPase signals
were normalised to the b-actin signals. RhoA, Rac1 and Cdc42 levels from untreated cells were set 1.0 (time = 0 h). The maximal RhoB level was set
1.0. The Rho-GTPases were analysed by the following antibodies: Rac1 with anti-Rac1(102) (d), Rac1 with anti-Rac1(23A8) (j), Cdc42 with anti-
Cdc42(44) (m), RhoA with anti-RhoA(26C4) (r), and RhoB with anti-RhoB(BL927) (.). The displayed Western blots are representative; the
depicted values are means of at least three independent experiments.
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cose moiety at Thr-35.
As glucosylation of RhoA at Thr-37 and Cdc42 at Thr-35
could also inﬂuence recognition by their respective antibodies,
increasing amounts of [14C]glucosylated and unmodiﬁed GST-
RhoA were analysed by Western blotting applying anti-RhoA
(Mab 26C4) and anti-GST (Pab Z-5). PhosphorImager analy-
sis visualised the presence of [14C]glucosylated GST-RhoA
(Fig. 3B). Glucosylated and unmodiﬁed GST-RhoA, however,
were equally recognised by both anti-RhoA (Mab 26C4) and
anti-GST (Pab Z-5), showing that glucosylation of RhoA did
not result in reduced recognition (Fig. 3B). Glucosylated and
unmodiﬁed GST-Cdc42 were also equally recognised
(Fig. 3C). In conclusion, glucosylation reduced recognition
of Rac1 by anti-Rac1 (Mab 102) but not by anti-Rac1 (Mab
23A8). In contrast, the recognition of RhoA by anti-RhoA
(Mab 26C4) and Cdc42 by anti-Cdc42 (Mab 44) was not inﬂu-
enced by their glucosylation.
To further show that decreasing Rac1 recognition is based
on its glucosylation, [14C]glucosylation of GST-Rac1 by TcdB
was analysed in a time-dependent manner (Fig. 4). The level of
Rac1 apparently decreased when analysed by anti-Rac1 (Mab
102); this decrease correlated with increasing [14C]glucosyla-
tion of Rac1 as visualised by PhosphorImaging (Fig. 4). The
presence of identical amounts of GST-Rac1 in the experiment
was conﬁrmed using anti-GST (Pab Z-5). Since the level ofGST-Rac1 remained stable throughout the experiment, the
decreasing levels of Rac1 detected by anti-Rac (Mab 102) re-
ﬂected its increasing glucosylation.4. Discussion
Up-to-date, Rac1 is the only substrate GTPase that is inac-
tivated by all clostridial glucosylating toxins [3]. Inactivation
of Rac1 by these toxins downregulates the NADPH oxidase,
which produces super oxide anions that inactivate infectious
pathogens [12]. Furthermore, Rac1 is involved in the regula-
tion of host cell invasion [13]. Modulation of Rac1 activity
has therefore been suggested to be a key factor of clostridial
glucosylating toxins to promote the survival of their producing
clostridia [14].
We found that treatment of ﬁbroblasts with TcdB caused an
apparent decrease of the cellular Rac1 level. This ﬁnding is in
line with several reports on reduced levels of Rac1 in several
TcdB-treated cell lines [6–8]. Within all these report, cellular
Rac1 levels were analysed using the commonly applied anti-
Rac1 (Mab 102). The decline of Rac1 protein from TcdB-trea-
ted cells had been interpreted as its degradation [6,8]. This
interpretation, however, was found to be lacking as apparent
Rac1 degradation was not inhibited by the proteasome inhib-
itors lactacystin and MG132. The cellular level of Rac1 and
Fig. 3. Recognition of [14C]glucosylated Rho-GTPases. Increasing
amounts of [14C]glucosylated or unmodiﬁed GST-tagged Rho-GTP-
ases were analysed by PhosphorImaging and Western blot analysis
using the indicated antibodies. For graphical depiction, Western signal
intensity was analysed densitometrically. Rac1 (A), RhoA (B), and
Cdc42 (C) were analysed by the indicated antibodies. The displayed
Western blots are representative; the depicted values are means of
three independent experiments.
Fig. 4. Recognition of in vitro glucosylated Rac1 (time dependent).
(A) GST-tagged Rac1 was incubated with TcdB and UDP-[14C]glucose
at 37 C. Increasing [14C]glucosylation of GST-Rac1 was analysed at
the indicated times by PhosphorImaging and Western blot analysis
using the indicated antibodies. For graphical depiction, Western blot
and autoradiography signal intensities were analysed densitometric-
ally. GST-Rac1 was analysed as follows: Rac1 with anti-Rac1(102)
(d), Rac1 with anti-GST(Z-5) (j), [14C]glucosylated Rac1 (m). The
displayed Western blot is representative; the depicted values are means
of at least three independent experiments.
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Applying the alternative anti-Rac1 (Mab 23A8) we showed
that the cellular Rac1 level did not decrease but increased in
TcdB-treated cells. Our observation is in line with one former
report showing the presence of glucosylated Rac1 in TcdB-
treated ﬁbroblasts using non-commercial anti-Rac1 [15].
Anti-Rac1 (Mab 23A8) obviously cross-reacted with a domain
on the Rac1 molecule that was distinct from the interaction
domain of anti-Rac1 (Mab 102). From our ﬁnding on reduced
Rac1 recognition after glucosylation at Thr-35, we conclude
that the interaction domain of anti-Rac1 (Mab 102) with
Rac1 includes the eﬀector I region (amino acids 28–40).The transient decrease of the RhoA and Cdc42 level in
TcdB-treated ﬁbroblasts, however, was due to degradation
by the proteasome, as lactacystin and MG132 eﬀectively stabi-
lised the respective GTPase levels. We suggest that the inacti-
vation of Rac1, Cdc42, and RhoA by glucosylation has
distinct eﬀects on cellular stability. Glucosylated Rac1 is sta-
ble, whereas glucosylation of RhoA and Cdc42 accelerates
their degradation. The reduced cellular stability of glucosy-
lated RhoA and Cdc42 may be part of the cellular defence
mechanism to restrict negative signalling by inactive Rho-
GTPases. Glucosylated Rho-GTPases are degraded, and
active GTPases are newly synthesised, as suggested for ADP-
ribosylated Rho [16]. Glucosylated Rac1, however, appeared
to escape from this mechanism. Glucosylated Rho-GTPases
are GTP-bound and not capable of binding to cytosolic guan-
ine nucleotide dissociation inhibitor (GDI)-l, so that glucosy-
lated Rho-GTPases are targeted to membranes [17,18]. In
this respect, glucosylated RhoA and Cdc42 on the one hand
and glucosylated Rac1 on the other hand may diﬀer in their
targeting to membranous sub-domains, resulting in distinct
cellular stability. In conclusion, the transient decrease of RhoA
and Cdc42 from TcdB-treated cells is due to their degradation.
In contrast, Rac1 was shown to be stably present in TcdB-trea-
ted ﬁbroblasts. The rapid loss of Rac1 in TcdB-treated cells
observed when applying the commonly used anti-Rac1 (Mab
102) is based on impaired recognition of glucosylated Rac1.
Studies on Rho glucosylating toxins has been performed using
Rho as a model GTPase, because it was possible to determine
cellular Rho glucosylation by sequential Rho ADP-ribosyla-
tion using exoenzyme C3 from C. botulinum [10]. Impaired
H. Genth et al. / FEBS Letters 580 (2006) 3565–3569 3569recognition of Rac1 by anti-Rac1 (Mab 102) turns out to be a
valuable tool to speciﬁcally estimate the glucosylation of Rac1
in cells treated with clostridial glucosylating toxins. Research-
ers will be able to better understand how glucosylating toxins
manipulate Rac1-dependent host cell signalling to promote
survival of the producing clostridia.
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